Summer Electric Bills Sizzle as Cooling Costs Rise Amid Hot Weather Oatly SWOT Analysis PlantBased Milk Makers Path to Profitability Under Scrutiny Hedge Funds Show Interest in Selected SmallCap Biotech Stocks Yahoo Finance Analysis Shows Healthcare and Tech Lead Broad Rally as SP 500 Inches Higher Trump Seeks Supreme Court Intervention to Halt TikTok Ban Patagonia Files Trademark Lawsuit Against Environmentalist Drag Performer Pattie Gonia ASTI Q1 2026 Earnings Wider Loss than Expected on No Revenue Stock Surges 27 The Lovesac Company LOVE Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Modestly AMR Q1 2026 Earnings Significant Earnings Miss Amid Challenging Conditions CELH Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction NOG Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance Calix Inc Q1 2026 Earnings EPS Meets Estimates Amid Steady Execution Tilray Brands TLRY Gains 18 as Cannabis Sector Eyes Key Resistance Power Solutions International PSIX Sees Slight Decline as Stock Tests Key Support Levels Perimeter Acquisition Corp I Warrant PMTRW Holds Steady at 077 Amid Consolidation Eaton Vance TaxManaged BuyWrite Income Fund ETB Edges Higher on Modest Uptick Cabot Corporation CBT Holds Near Support Modest Price Recovery May Signal Consolidation NATO Defense Spending Surge and US Troop Deployment to Poland Signal Geopolitical Shift IMRX Q1 2026 Earnings EPS Surpasses Estimates as Clinical Pipeline Advances Ideal Power Inc IPWR Surges 19 Key Levels and Technical Setup After Breakout ACIW Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Higher EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge MOMO Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines LIXT Q4 2024 Earnings PreRevenue Biotech Reports PerShare Loss as Stock Jumps 136 GRPN Q1 2026 Earnings EPS Misses Analysts Expectations by a Wide Margin Revenue Not Disclosed LULU Q1 2026 Earnings EPS Beats Estimates Stock Rises Beyond Air Inc XAIR Q1 2026 Earnings Narrowed Loss Slightly Exceeds Expectations as Clinical Pipeline Advances